Post by
wildbird1 on Apr 26, 2023 10:37am
Vaccine news in 1Q2023.
In the pressrelease Nov 29, 2022...
TLT said " Theralase is currently designing and developing a new proprietary light activation specifically, the TLT-3000B, to inactivate the virus and create the fundamental building block of a COVID-19 vaccine. The TLT-3000B is expected to be completed for use by PHAC(Public Health Agency Canada) and NRC(National Reasearch Council Canada) in Q1,2023".
Aug 29,2020 pressrelease..
TLT said" TLT believe it can develop an elegant solution that will help mitigate virus threat quickly and efficiently".
In this context elegant mean, a rapid, simple, and inexpensive way to develop future vaccines.
Feb 7,2022 pressrelease...
TLT said" TLT platform is extremely versatile, with an ability to be applicable to a wide range of virus".
The above mean TLT solution is about any virus present and future, not only COVID-19.
The next update on the TLT-3000B should be very interesting.
Comment by
Rumpl3StiltSkin on Apr 26, 2023 10:49am
That is interesting, I always thought 1433 was somewhat limited on the virus front. Very good against corona type virii, for instance. 1433 is 100% effective against bacterium though. So I would expect it to offer an 'elegant' alternative to Anti Biotics, some day.